65 related articles for article (PubMed ID: 1429075)
21. Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients.
Yerly S; Denereaz N; Mermillod B; Hirschel B; Perrin L
Antivir Ther; 1996 Aug; 1(3):167-71. PubMed ID: 11322250
[TBL] [Abstract][Full Text] [Related]
22. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
23. The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
Molina JM; Chêne G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM
J Infect Dis; 1999 Aug; 180(2):351-8. PubMed ID: 10395849
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
[No Abstract] [Full Text] [Related]
25. [Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
López-Martínez C; Guarner J; Magis-Rodríguez C; Uribe-Zúñiga P; del Río-Chiriboga C
Rev Invest Clin; 1998; 50(4):335-9. PubMed ID: 9830323
[TBL] [Abstract][Full Text] [Related]
26. [Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients].
Reynes J; Montes B; Delmas B; Vendrell JP; Janbon F; Segondy M
Pathol Biol (Paris); 1997 May; 45(5):441-4. PubMed ID: 9296101
[TBL] [Abstract][Full Text] [Related]
27. [Combination therapies with anti-retroviral agents in HIV and AIDS infections].
Fernández-Cruz E
Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345
[No Abstract] [Full Text] [Related]
28. Study of AZT effectiveness in treating HIV-infected children halted.
J Am Osteopath Assoc; 1995 Mar; 95(3):211. PubMed ID: 7751172
[No Abstract] [Full Text] [Related]
29. [Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].
Stamminger T; Fleckenstein B
Fortschr Med; 1994 May; 112(13):190-1. PubMed ID: 8020860
[No Abstract] [Full Text] [Related]
30. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
Foli A; Maserati R; Minoli L; Wainberg MA; Gallo RC; Lisziewicz J; Lori F
AIDS; 1998 Jun; 12(9):1113-4. PubMed ID: 9662215
[No Abstract] [Full Text] [Related]
31. New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
Fischl MA
AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100
[No Abstract] [Full Text] [Related]
32. Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine.
Chrétien F; Gray F; de Truchis P; Bélec L; Levy Y; Dubreuil-Lemaire ML
Antimicrob Agents Chemother; 1996 Jan; 40(1):278. PubMed ID: 8787925
[No Abstract] [Full Text] [Related]
33. Didanosine and ACTG 116A.
Higgins S; Woolley PD; Chandiok S
Lancet; 1993 Feb; 341(8844):570. PubMed ID: 8094822
[No Abstract] [Full Text] [Related]
34. Treating HIV infection: what pharmacists need to know.
Wong RJ
Am Pharm; 1993 May; NS33(5):57-64. PubMed ID: 8333410
[No Abstract] [Full Text] [Related]
35. [AIDS therapy--new perspectives for the 90s].
Immun Infekt; 1991 Feb; 19(1):III. PubMed ID: 2060959
[No Abstract] [Full Text] [Related]
36. Clinical perspectives in the treatment of HIV disease: the role of didanosine. Chicago, Illinois, 28 September 1991.
Clin Infect Dis; 1993 Feb; 16 Suppl 1():S1-73. PubMed ID: 8425016
[No Abstract] [Full Text] [Related]
37. Clinical perspectives in the treatment of HIV disease: the role of didanosine. Introduction.
Corey L
Clin Infect Dis; 1993 Feb; 16 Suppl 1():S1. PubMed ID: 8425015
[No Abstract] [Full Text] [Related]
38. BDEWF New Writers' Workshop.
Br Dent J; 2020 Jul; 229(2):85. PubMed ID: 32710049
[No Abstract] [Full Text] [Related]
39. New Writers' Workshop returns.
Br Dent J; 2021 Sep; 231(6):321. PubMed ID: 34561571
[No Abstract] [Full Text] [Related]
40. Editorial introduction.
Curr Opin HIV AIDS; 2024 Jul; 19(4):v. PubMed ID: 38841849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
